SAB Biotherapeutics, Inc. (SABS)
NASDAQ
$3.51-0.85%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 444,799
- 52-week high
- —
- 52-week low
- —
- Open
- $3.54
- Day high
- $3.62
- Day low
- $3.47
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $0 | $13.27M | -$0.79 |
| 2024 | $1.32M | -$34.11M | -$3.68 |
| 2023 | $2.24M | -$42.19M | -$7.64 |
| 2022 | $23.9M | -$18.74M | -$4.31 |
| 2021 | $60.88M | -$17.14M | -$0.63 |
About SAB Biotherapeutics, Inc.
A company overview for SAB Biotherapeutics, Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is SAB Biotherapeutics, Inc.'s stock price today?
- SABS is trading at $3.51 as of Jul 20, 2026.
- Does SAB Biotherapeutics, Inc. pay a dividend?
- SAB Biotherapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.